Analogic (NASDAQ:ALOG) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Saturday, January 6th.
ALOG has been the subject of several other reports. Jefferies Group reiterated a “hold” rating and set a $75.00 target price on shares of Analogic in a report on Wednesday, September 20th. Zacks Investment Research upgraded shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a report on Friday, December 8th.
Shares of Analogic (NASDAQ:ALOG) traded down $0.95 on Friday, reaching $84.40. 40,051 shares of the company’s stock traded hands, compared to its average volume of 74,210. Analogic has a twelve month low of $66.00 and a twelve month high of $89.50. The stock has a market capitalization of $1,050.00, a price-to-earnings ratio of -14.78, a PEG ratio of 4.26 and a beta of 0.86.
Analogic (NASDAQ:ALOG) last issued its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.32. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The business had revenue of $106.90 million during the quarter, compared to analyst estimates of $100.55 million. During the same period last year, the business posted $0.43 earnings per share. Analogic’s quarterly revenue was down 11.7% compared to the same quarter last year. equities research analysts forecast that Analogic will post 2.86 EPS for the current year.
Several hedge funds have recently added to or reduced their stakes in ALOG. Schwab Charles Investment Management Inc. lifted its holdings in shares of Analogic by 53.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 111,126 shares of the medical research company’s stock valued at $8,074,000 after purchasing an additional 38,698 shares during the last quarter. First Trust Advisors LP increased its position in shares of Analogic by 11.0% during the second quarter. First Trust Advisors LP now owns 11,278 shares of the medical research company’s stock valued at $819,000 after acquiring an additional 1,116 shares in the last quarter. Rhumbline Advisers increased its position in shares of Analogic by 1.4% during the second quarter. Rhumbline Advisers now owns 29,900 shares of the medical research company’s stock valued at $2,172,000 after acquiring an additional 418 shares in the last quarter. SG Americas Securities LLC increased its position in shares of Analogic by 470.7% during the second quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock valued at $554,000 after acquiring an additional 6,284 shares in the last quarter. Finally, Legal & General Group Plc increased its position in shares of Analogic by 7.7% during the second quarter. Legal & General Group Plc now owns 23,749 shares of the medical research company’s stock valued at $1,725,000 after acquiring an additional 1,696 shares in the last quarter. Hedge funds and other institutional investors own 97.68% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This article was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/13/analogic-alog-rating-lowered-to-strong-sell-at-bidaskclub.html.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.